The animal wound care products ecosystem spans from raw biomaterial and active-ingredient suppliers through device manufacturers, integrative packagers, and multi-tier distribution to the point of care. Upstream inputs—biopolymers, antimicrobials, sterile films—are converted into dressings, glues, sutures, and sprays; value accrues as components acquire regulatory status and validated shelf life. Midstream firms blend active compounds, assemble finished formats, and perform sterility testing, creating differentiated SKUs that meet species-specific or practice-type protocols. Downstream channels include veterinary wholesalers, co-operatives, group purchasing organisations, and direct-to-clinic e-commerce platforms that hold inventory risk and deliver last-mile logistics. Value capture shifts from manufacturers holding intellectual property to distributors controlling access and data on prescription patterns, while veterinarians and livestock producers ultimately decide usage frequency and brand adherence.